Association between the profile of patients with chronic myeloid leukemia and adherence to tyrosine kinase inhibitors
Journal of Oncology Pharmacy Practice
Published online on March 17, 2025
Abstract
Journal of Oncology Pharmacy Practice, Ahead of Print.
BackgroundTyrosine kinase inhibitors have substantially improved the quality of life and survival of patients with chronic myeloid leukemia. However, adherence is a complex and crucial aspect for achieving the desired clinical outcomes. Various factors ...
BackgroundTyrosine kinase inhibitors have substantially improved the quality of life and survival of patients with chronic myeloid leukemia. However, adherence is a complex and crucial aspect for achieving the desired clinical outcomes. Various factors ...